{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T13:54:47Z","timestamp":1794318887838,"version":"4.9.0"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,8,8]],"date-time":"2023-08-08T00:00:00Z","timestamp":1691452800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,8]],"date-time":"2023-08-08T00:00:00Z","timestamp":1691452800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["R01CA214384"],"award-info":[{"award-number":["R01CA214384"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["R01CA243916"],"award-info":[{"award-number":["R01CA243916"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Biomaterial scaffolds mimicking the environment in metastatic organs can deconstruct complex signals and facilitate the study of cancer progression and metastasis. Here we report that a subcutaneous scaffold implant in mouse models of metastatic breast cancer in female mice recruits lung-tropic circulating tumor cells yet suppresses their growth through potent in situ antitumor immunity. In contrast, the lung, the endogenous metastatic organ for these models, develops lethal metastases in aggressive\u00a0breast cancer, with less aggressive tumor models developing dormant lungs suppressing tumor growth. Our study reveals multifaceted roles of neutrophils in regulating metastasis. Breast cancer-educated neutrophils infiltrate the scaffold implants and lungs, secreting the same signal to attract lung-tropic circulating tumor cells. Second, antitumor and pro-tumor neutrophils are selectively recruited to the dormant scaffolds and lungs, respectively, responding to distinct groups of chemoattractants to establish activated or suppressive immune environments that direct different fates of cancer cells.<\/jats:p>","DOI":"10.1038\/s41467-023-40478-5","type":"journal-article","created":{"date-parts":[[2023,8,8]],"date-time":"2023-08-08T18:01:55Z","timestamp":1691517715000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["A synthetic metastatic niche reveals antitumor neutrophils drive breast cancer metastatic dormancy in the lungs"],"prefix":"10.1038","volume":"14","author":[{"given":"Jing","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramon","family":"Ocadiz-Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew S.","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace G.","family":"Bushnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophia M.","family":"Orbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7914-4741","authenticated-orcid":false,"given":"Joseph T.","family":"Decker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravi M.","family":"Raghani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yining","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4680-2493","authenticated-orcid":false,"given":"Aaron H.","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-4554-379X","authenticated-orcid":false,"given":"Jacqueline S.","family":"Jeruss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9296-9673","authenticated-orcid":false,"given":"Lonnie D.","family":"Shea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,8]]},"reference":[{"key":"40478_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21654","volume":"71","author":"RL Siegel","year":"2021","unstructured":"Siegel, R. L., Miller, K. D., Fuchs, H. E. & Jemal, A. Cancer statistics, 2021. CA Cancer J. Clin. 71, 7\u201333 (2021).","journal-title":"CA Cancer J. Clin."},{"key":"40478_CR2","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1038\/nrc2622","volume":"9","author":"DX Nguyen","year":"2009","unstructured":"Nguyen, D. X., Bos, P. D. & Massagu\u00e9, J. Metastasis: from dissemination to organ-specific colonization. Nat. Rev. Cancer 9, 274\u2013284 (2009).","journal-title":"Nat. Rev. Cancer"},{"key":"40478_CR3","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1016\/S1470-2045(08)70201-8","volume":"9","author":"IJ Fidler","year":"2008","unstructured":"Fidler, I. J. & Poste, G. The \u201cseed and soil\u201d hypothesis revisited. Lancet Oncol. 9, 808 (2008).","journal-title":"Lancet Oncol."},{"key":"40478_CR4","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/j.cell.2013.10.029","volume":"155","author":"FG Giancotti","year":"2013","unstructured":"Giancotti, F. G. Mechanisms governing metastatic dormancy and reactivation. Cell 155, 750\u2013764 (2013).","journal-title":"Cell"},{"key":"40478_CR5","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1111\/cas.13917","volume":"2","author":"H Endo","year":"2019","unstructured":"Endo, H. & Inoue, M. Dormancy in cancer. Cancer Sci. 2, 474\u2013480 (2019).","journal-title":"Cancer Sci."},{"key":"40478_CR6","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/nrc2618","volume":"9","author":"JA Joyce","year":"2009","unstructured":"Joyce, J. A. & Pollard, J. W. Microenvironmental regulation of metastasis. Nat. Rev. Cancer 9, 239\u2013252 (2009).","journal-title":"Nat. Rev. Cancer"},{"key":"40478_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/s13036-018-0137-0","volume":"13","author":"SS Rao","year":"2019","unstructured":"Rao, S. S., Kondapaneni, R. V. & Narkhede, A. A. Bioengineered models to study tumor dormancy. J. Biol. Eng. 13, 3 (2019).","journal-title":"J. Biol. Eng."},{"key":"40478_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41523-021-00269-x","volume":"7","author":"GG Bushnell","year":"2021","unstructured":"Bushnell, G. G. et al. Breast cancer dormancy: need for clinically relevant models to address current gaps in knowledge. NPJ Breast Cancer 7, 66 (2021).","journal-title":"NPJ Breast Cancer"},{"key":"40478_CR9","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.3390\/cancers11081080","volume":"11","author":"CA Edechi","year":"2019","unstructured":"Edechi, C. A., Ikeogu, N., Uzonna, J. E. & Myal, Y. Regulation of immunity in breast cancer. Cancers 11, 1080 (2019).","journal-title":"Cancers"},{"key":"40478_CR10","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1038\/s41392-021-00817-8","volume":"22","author":"D Lin","year":"2021","unstructured":"Lin, D. et al. Circulating tumor cells: biology and clinical significance. Signal Transduct. Target Ther. 22, 404 (2021).","journal-title":"Signal Transduct. Target Ther."},{"key":"40478_CR11","doi-asserted-by":"publisher","first-page":"0077","DOI":"10.1038\/s41551-017-0077","volume":"1","author":"BA Aguado","year":"2017","unstructured":"Aguado, B. A. et al. Engineering the pre-metastatic niche. Nat. Biomed. Eng. 1, 0077 (2017).","journal-title":"Nat. Biomed. Eng."},{"key":"40478_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms9094","volume":"6","author":"SM Azarin","year":"2015","unstructured":"Azarin, S. M. et al. In vivo capture and label-free detection of early metastatic cells. Nat. Commun. 6, 8094 (2015).","journal-title":"Nat. Commun."},{"key":"40478_CR13","doi-asserted-by":"publisher","first-page":"5209","DOI":"10.1158\/0008-5472.CAN-15-2106","volume":"76","author":"SS Rao","year":"2016","unstructured":"Rao, S. S. et al. Enhanced survival with implantable scaffolds that capture metastatic breast cancer cells in vivo. Cancer Res. 76, 5209\u20135218 (2016).","journal-title":"Cancer Res."},{"key":"40478_CR14","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.1158\/0008-5472.CAN-18-2502","volume":"79","author":"GG Bushnell","year":"2019","unstructured":"Bushnell, G. G. et al. Biomaterial scaffolds recruit an aggressive population of metastatic tumor cells in vivo. Cancer Res. 79, 2042\u20132053 (2019).","journal-title":"Cancer Res."},{"key":"40478_CR15","doi-asserted-by":"publisher","first-page":"19638","DOI":"10.1073\/pnas.1208384109","volume":"109","author":"J Lee","year":"2012","unstructured":"Lee, J. et al. Implantable microenvironments to attract hematopoietic stem\/cancer cells. Proc. Natl Acad. Sci. USA 109, 19638\u201319643 (2012).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"40478_CR16","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.biomaterials.2015.01.076","volume":"51","author":"FP Seib","year":"2015","unstructured":"Seib, F. P., Berry, J. E., Shiozawa, Y., Taichman, R. S. & Kaplan, D. L. Tissue engineering a surrogate niche for metastatic cancer cells. Biomaterials 51, 313\u2013319 (2015).","journal-title":"Biomaterials"},{"key":"40478_CR17","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.actbio.2016.01.043","volume":"33","author":"BA Aguado","year":"2016","unstructured":"Aguado, B. A. et al. Extracellular matrix mediators of metastatic cell colonization characterized using scaffold mimics of the pre-metastatic niche. Acta Biomater. 33, 13\u201324 (2016).","journal-title":"Acta Biomater."},{"key":"40478_CR18","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1038\/s41551-018-0307-x","volume":"2","author":"RA Carpenter","year":"2018","unstructured":"Carpenter, R. A., Kwak, J., Peyton, S. R. & Lee, J. Implantable pre-metastatic niches for the study of the microenvironmental regulation of disseminated human tumour cells. Nat. Biomed. Eng. 2, 915\u2013929 (2018).","journal-title":"Nat. Biomed. Eng."},{"key":"40478_CR19","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/s41577-021-00571-6","volume":"22","author":"CC Hedrick","year":"2022","unstructured":"Hedrick, C. C. & Malanchi, I. Neutrophils in cancer: heterogeneous and multifaceted. Nat. Rev. Immunol. 22, 173\u2013187 (2022).","journal-title":"Nat. Rev. Immunol."},{"key":"40478_CR20","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/s41586-019-0915-y","volume":"566","author":"BM Szczerba","year":"2019","unstructured":"Szczerba, B. M. et al. Neutrophils escort circulating tumour cells to enable cell cycle progression. Nature 566, 553\u2013557 (2019).","journal-title":"Nature"},{"key":"40478_CR21","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.ccr.2009.06.017","volume":"16","author":"ZG Fridlender","year":"2009","unstructured":"Fridlender, Z. G. et al. Polarization of tumor-associated neutrophils (TAN) phenotype by TGF\u03b2: \u201cN1\u201d versus \u201cN2\u201d TAN. Cancer Cell 16, 183\u2013194 (2009).","journal-title":"Cancer Cell"},{"key":"40478_CR22","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.3390\/polym13071105","volume":"13","author":"MSB Reddy","year":"2021","unstructured":"Reddy, M. S. B., Ponnamma, D., Choudhary, R. & Sadasivuni, K. K. A comparative review of natural and synthetic biopolymer composite scaffolds. Polymers 13, 1105 (2021).","journal-title":"Polymers"},{"key":"40478_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms12150","volume":"7","author":"V Bronte","year":"2016","unstructured":"Bronte, V. et al. Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards. Nat. Commun. 7, 12150 (2016).","journal-title":"Nat. Commun."},{"key":"40478_CR24","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.ccell.2016.09.011","volume":"30","author":"Y Liu","year":"2016","unstructured":"Liu, Y. & Cao, X. Characteristics and significance of the pre-metastatic niche. Cancer Cell 30, 668\u2013681 (2016).","journal-title":"Cancer Cell"},{"key":"40478_CR25","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1159\/000330095","volume":"4","author":"G Srikrishna","year":"2012","unstructured":"Srikrishna, G. S100A8 and S100A9: new insights into their roles in malignancy. J. Innate Immun. 4, 31\u201340 (2012).","journal-title":"J. Innate Immun."},{"key":"40478_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-16596-9","volume":"11","author":"G Boivin","year":"2020","unstructured":"Boivin, G. et al. Durable and controlled depletion of neutrophils in mice. Nat. Commun. 11, 2762 (2020).","journal-title":"Nat. Commun."},{"key":"40478_CR27","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1038\/ncb1507","volume":"8","author":"S Hiratsuka","year":"2006","unstructured":"Hiratsuka, S., Watanabe, A., Aburatani, H. & Maru, Y. Tumour-mediated upregulation of chemoattractants and recruitment of myeloid cells predetermines lung metastasis. Nat. Cell Biol. 8, 1369\u20131375 (2006).","journal-title":"Nat. Cell Biol."},{"key":"40478_CR28","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1038\/nature03799","volume":"436","author":"AJ Minn","year":"2005","unstructured":"Minn, A. J. et al. Genes that mediate breast cancer metastasis to lung. Nature 436, 518\u2013524 (2005).","journal-title":"Nature"},{"key":"40478_CR29","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/nrc3055","volume":"11","author":"KN Weilbaecher","year":"2011","unstructured":"Weilbaecher, K. N., Guise, T. A. & McCauley, L. K. Cancer to bone: a fatal attraction. Nat. Rev. Cancer 11, 411\u2013425 (2011).","journal-title":"Nat. Rev. Cancer"},{"key":"40478_CR30","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/S1535-6108(03)00132-6","volume":"3","author":"Y Kang","year":"2003","unstructured":"Kang, Y. et al. A multigenic program mediating breast cancer metastasis to bone. Cancer Cell 3, 537\u2013549 (2003).","journal-title":"Cancer Cell"},{"key":"40478_CR31","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1002\/bit.26293","volume":"114","author":"JT Decker","year":"2017","unstructured":"Decker, J. T. et al. Systems analysis of dynamic transcription factor activity identifies targets for treatment in olaparib resistant cancer cells. Biotechnol. Bioeng. 114, 2085\u20132095 (2017).","journal-title":"Biotechnol. Bioeng."},{"key":"40478_CR32","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.smim.2007.11.004","volume":"20","author":"JM Anderson","year":"2008","unstructured":"Anderson, J. M., Rodriguez, A. & Chang, D. T. Foreign body reaction to biomaterials. Semin. Immunol. 20, 86\u2013100 (2008).","journal-title":"Semin. Immunol."},{"key":"40478_CR33","doi-asserted-by":"crossref","unstructured":"Moriarty, T. F., Zaat, S. A. M. & Busscher, H. J. Biomaterials Associated Infections: Immunological Aspects and Antimicrobial Strategies (Springer, New York, 2012).","DOI":"10.1007\/978-1-4614-1031-7"},{"key":"40478_CR34","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41577-019-0210-z","volume":"20","author":"SK Wculek","year":"2020","unstructured":"Wculek, S. K. et al. Dendritic cells in cancer immunology and immunotherapy. Nat. Rev. Immunol. 20, 7\u201324 (2020).","journal-title":"Nat. Rev. Immunol."},{"key":"40478_CR35","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.cell.2010.03.014","volume":"141","author":"B Qian","year":"2010","unstructured":"Qian, B. & Pollard, J. W. Macrophage diversity enhances tumor progression and metastasis. Cell 141, 39\u201351 (2010).","journal-title":"Cell"},{"key":"40478_CR36","doi-asserted-by":"publisher","first-page":"5488","DOI":"10.1182\/blood-2008-10-187179","volume":"113","author":"L Chiossone","year":"2009","unstructured":"Chiossone, L. et al. Maturation of mouse NK cells is a 4-stage developmental program. Blood 113, 5488\u20135496 (2009).","journal-title":"Blood"},{"key":"40478_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22973-9","volume":"12","author":"R Grieshaber-Bouyer","year":"2021","unstructured":"Grieshaber-Bouyer, R. et al. The neutrotime transcriptional signature defines a single continuum of neutrophils across biological compartments. Nat. Commun. 12, 2856 (2021).","journal-title":"Nat. Commun."},{"key":"40478_CR38","doi-asserted-by":"publisher","first-page":"602963","DOI":"10.3389\/fimmu.2021.602963","volume":"12","author":"E McKenna","year":"2021","unstructured":"McKenna, E. et al. Neutrophils: need for standardized nomenclature. Front. Immunol. 12, 602963 (2021).","journal-title":"Front. Immunol."},{"key":"40478_CR39","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.it.2015.02.009","volume":"36","author":"A Lasry","year":"2015","unstructured":"Lasry, A. & Ben-Neriah, Y. Senescence-associated inflammatory responses: aging and cancer perspectives. Trends Immunol. 36, 217\u2013228 (2015).","journal-title":"Trends Immunol."},{"key":"40478_CR40","doi-asserted-by":"publisher","first-page":"eaax3799","DOI":"10.1126\/scitranslmed.aax3799","volume":"12","author":"L Chung","year":"2020","unstructured":"Chung, L. et al. Interleukin 17 and senescent cells regulate the foreign body response to synthetic material implants in mice and humans. Sci. Transl. Med. 12, eaax3799 (2020).","journal-title":"Sci. Transl. Med."},{"key":"40478_CR41","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1038\/nature04651","volume":"440","author":"F Castellino","year":"2006","unstructured":"Castellino, F. et al. Chemokines enhance immunity by guiding naive CD8+ T cells to sites of CD4+ T cell\u2013dendritic cell interaction. Nature 440, 890\u2013895 (2006).","journal-title":"Nature"},{"key":"40478_CR42","doi-asserted-by":"publisher","first-page":"976","DOI":"10.3389\/fimmu.2020.00976","volume":"11","author":"N Karin","year":"2020","unstructured":"Karin, N. CXCR3 ligands in cancer and autoimmunity, chemoattraction of effector T cells, and beyond. Front. Immunol. 11, 976 (2020).","journal-title":"Front. Immunol."},{"key":"40478_CR43","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1016\/j.cell.2018.01.004","volume":"172","author":"JP B\u00f6ttcher","year":"2018","unstructured":"B\u00f6ttcher, J. P. et al. NK cells stimulate recruitment of cDC1 into the tumor microenvironment promoting cancer immune control. Cell 172, 1022\u20131037 (2018).","journal-title":"Cell"},{"key":"40478_CR44","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/S0065-230X(03)90004-2","volume":"90","author":"J Wu","year":"2003","unstructured":"Wu, J. & Lanier, L. L. Natural killer cells and cancer. Adv. Cancer Res. 90, 127\u2013156 (2003).","journal-title":"Adv. Cancer Res."},{"key":"40478_CR45","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1016\/j.cell.2008.03.038","volume":"133","author":"JC Acosta","year":"2008","unstructured":"Acosta, J. C. et al. Chemokine signaling via the CXCR2 receptor reinforces senescence. Cell 133, 1006\u20131008 (2008).","journal-title":"Cell"},{"key":"40478_CR46","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/nature11824","volume":"494","author":"H Braum\u00fcller","year":"2013","unstructured":"Braum\u00fcller, H. et al. T-helper-1-cell cytokines drive cancer into senescence. Nature 494, 361\u2013365 (2013).","journal-title":"Nature"},{"key":"40478_CR47","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1038\/s41577-020-00490-y","volume":"21","author":"F Veglia","year":"2021","unstructured":"Veglia, F., Sanseviero, E. & Gabrilovich, D. I. Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity. Nat. Rev. Immunol. 21, 485\u2013498 (2021).","journal-title":"Nat. Rev. Immunol."},{"key":"40478_CR48","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1038\/s41577-021-00566-3","volume":"22","author":"AM Gocher","year":"2022","unstructured":"Gocher, A. M., Workman, C. J. & Vignali, D. A. A. Interferon-r: teammate or opponent in the tumor environment. Nat. Rev. Immunol. 22, 158\u2013172 (2022).","journal-title":"Nat. Rev. Immunol."},{"key":"40478_CR49","doi-asserted-by":"publisher","first-page":"815","DOI":"10.3390\/cells8080815","volume":"8","author":"A Lamort","year":"2019","unstructured":"Lamort, A., Giopanou, I., Psallidas, I. & Stathopoulous, G. T. Osteopontin as a link between inflammation and cancer: the thorax in the spotlight. Cells 8, 815 (2019).","journal-title":"Cells"},{"key":"40478_CR50","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1038\/s41586-019-1526-3","volume":"573","author":"V Padmanaban","year":"2019","unstructured":"Padmanaban, V. et al. E-cadherin is required for metastasis in multiple models of breast cancer. Nature 573, 439\u2013444 (2019).","journal-title":"Nature"},{"key":"40478_CR51","doi-asserted-by":"crossref","unstructured":"J\u00e4rvinen, T. A. H. & Prince, S. Decorin: a growth factor antagonist for tumor growth inhibition. Biomed. Res. Int. 2015, 654765 (2015).","DOI":"10.1155\/2015\/654765"},{"key":"40478_CR52","doi-asserted-by":"publisher","first-page":"5835","DOI":"10.1016\/j.biomaterials.2005.03.003","volume":"26","author":"AT Tsai","year":"2005","unstructured":"Tsai, A. T. et al. The role of osteopontin in foreign body giant cell formation. Biomaterials 26, 5835\u20135843 (2005).","journal-title":"Biomaterials"},{"key":"40478_CR53","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1163\/156856208784909408","volume":"19","author":"WK Ward","year":"2008","unstructured":"Ward, W. K., Li, A. G., Siddiqui, Y., Federiuk, I. F. & Wang, X. Increased expression of Interleukin-13 and connective tissue growth factor, and their potential roles during foreign body encapsulation of subcutaneous implants. J. Biomater. Sci. 19, 1065\u20131072 (2008).","journal-title":"J. Biomater. Sci."},{"key":"40478_CR54","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1002\/ijc.29945","volume":"138","author":"L Andzinski","year":"2016","unstructured":"Andzinski, L. et al. Type I IFNs induce anti-tumor polarization of tumor associated neutrophils in mice and human. Int. J. Cancer 138, 1982\u20131993 (2016).","journal-title":"Int. J. Cancer"},{"key":"40478_CR55","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1186\/bcr77","volume":"2","author":"GH Heppner","year":"2000","unstructured":"Heppner, G. H., Miller, F. R. & Shekhar, P. M. Nontransgenic models of breast cancer. Breast Cancer Res. 2, 331\u2013334 (2000).","journal-title":"Breast Cancer Res."},{"key":"40478_CR56","first-page":"237","volume":"8","author":"CN Johnstone","year":"2015","unstructured":"Johnstone, C. N. et al. Functional and molecular characterisation of EO771.LMB tumours, a new C57BL\/6-mouse-derived model of spontaneously metastatic mammary cancer. Dis. Models Mech. 8, 237\u2013251 (2015).","journal-title":"Dis. Models Mech."},{"key":"40478_CR57","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1097\/01.shk.0000142249.08135.e9","volume":"22","author":"H Watanabe","year":"2004","unstructured":"Watanabe, H., Numata, K., Ito, T. & Takagi, K. A. Matsukawa, Innate immune response in Th1 and Th2-dominant mouse strains. Shock 22, 460\u2013466 (2004).","journal-title":"Shock"},{"key":"40478_CR58","doi-asserted-by":"publisher","first-page":"333","DOI":"10.3389\/fimmu.2019.00333","volume":"10","author":"AE Vilgelm","year":"2019","unstructured":"Vilgelm, A. E. & Richmond, A. Chemokines modulate immune surveillance in tumorigenesis, metastasis, and response to immunotherapy. Front. Immunol. 10, 333 (2019).","journal-title":"Front. Immunol."},{"key":"40478_CR59","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1158\/0008-5472.CAN-19-1932","volume":"80","author":"RS Oakes","year":"2020","unstructured":"Oakes, R. S. et al. Metastatic conditioning of myeloid cells at a subcutaneous synthetic niche reflects disease progression and predicts therapeutic outcomes. Cancer Res. 80, 602\u2013612 (2020).","journal-title":"Cancer Res."},{"key":"40478_CR60","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1007\/s10549-009-0674-9","volume":"3","author":"B Gy\u00f6rffy","year":"2010","unstructured":"Gy\u00f6rffy, B. et al. An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1809 patients. Breast Cancer Res. Treat. 3, 725\u2013731 (2010).","journal-title":"Breast Cancer Res. Treat."},{"key":"40478_CR61","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/j.celrep.2014.12.039","volume":"10","author":"JY Sagiv","year":"2015","unstructured":"Sagiv, J. Y. et al. Phenotypic diversity and plasticity in circulating neutrophil subpopulations in cancer. Cell Rep. 10, 562\u2013573 (2015).","journal-title":"Cell Rep."},{"key":"40478_CR62","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.biomaterials.2018.11.002","volume":"192","author":"K Sadtler","year":"2019","unstructured":"Sadtler, K. et al. Divergent immune responses to synthetic and biological scaffolds. Biomaterials 192, 405\u2013415 (2019).","journal-title":"Biomaterials"},{"key":"40478_CR63","doi-asserted-by":"publisher","first-page":"djv184","DOI":"10.1093\/jnci\/djv184","volume":"107","author":"A De la Fuente","year":"2015","unstructured":"De la Fuente, A. et al. M-Trap: exosome-based capture of tumor cells as a new technology in peritoneal metastasis. J. Natl Cancer Inst. 107, djv184 (2015).","journal-title":"J. Natl Cancer Inst."},{"key":"40478_CR64","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.ygyno.2021.03.022","volume":"161","author":"A Gil-Morena","year":"2021","unstructured":"Gil-Morena, A. et al. M-TRAP: safety and performance of metastatic tumor cell trap device in advanced ovarian cancer patients. Gynecol. Oncol. 161, 681\u2013686 (2021).","journal-title":"Gynecol. Oncol."},{"key":"40478_CR65","doi-asserted-by":"publisher","first-page":"120666","DOI":"10.1016\/j.biomaterials.2021.120666","volume":"269","author":"Y Zhang","year":"2021","unstructured":"Zhang, Y. et al. Cargo-free immunomodulatory nanoparticles combined with anti-PD-1 antibody for treating metastatic breast cancer. Biomaterials 269, 120666 (2021).","journal-title":"Biomaterials"},{"key":"40478_CR66","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1038\/s41578-020-0209-x","volume":"5","author":"AK Gaharwar","year":"2020","unstructured":"Gaharwar, A. K., Singh, I. & Khademhosseini, A. Engineered biomaterials for in situ tissue regeneration. Nat. Rev. Mater. 5, 686\u2013705 (2020).","journal-title":"Nat. Rev. Mater."},{"key":"40478_CR67","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1126\/science.aad9272","volume":"352","author":"K Sadtler","year":"2016","unstructured":"Sadtler, K. et al. Developing a pro-regenerative biomaterial scaffold microenvironment requires T helper 2 cells. Science 352, 366\u2013370 (2016).","journal-title":"Science"},{"key":"40478_CR68","doi-asserted-by":"publisher","first-page":"eaat7973","DOI":"10.1126\/scitranslmed.aat7973","volume":"11","author":"MT Wolf","year":"2019","unstructured":"Wolf, M. T. et al. A biologic scaffold-associated type 2 immune microenvironment inhibits tumor formation and synergizes with checkpoint immunotherapy. Sci. Transl. Med. 11, eaat7973 (2019).","journal-title":"Sci. Transl. Med."},{"key":"40478_CR69","doi-asserted-by":"publisher","first-page":"e64181","DOI":"10.1371\/journal.pone.0064181","volume":"8","author":"RE Hurst","year":"2013","unstructured":"Hurst, R. E. et al. Suppression and activation of the malignant phenotype by extracellular matrix in xenograft models of bladder cancer: a model for tumor cell \u201cdormancy\u201d. PLoS ONE 8, e64181 (2013).","journal-title":"PLoS ONE"},{"key":"40478_CR70","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-016-0798-8","volume":"14","author":"JY Fang","year":"2016","unstructured":"Fang, J. Y., Tang, S., Wu, Y., Yang, Z. & Hoang, B. X. From competency to dormancy: a 3D model to study cancer cells and drug responsiveness. J. Transl. Med. 14, 38 (2016).","journal-title":"J. Transl. Med."},{"key":"40478_CR71","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1093\/carcin\/bgh261","volume":"26","author":"C Khanna","year":"2005","unstructured":"Khanna, C. & Hunter, K. Modeling metastasis in vivo. Carcinogenesis 26, 513\u2013523 (2005).","journal-title":"Carcinogenesis"},{"key":"40478_CR72","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17629-z","volume":"11","author":"AH Morris","year":"2020","unstructured":"Morris, A. H. et al. Engineered immunological niches to monitor disease activity and treatment efficacy in relapsing multiple sclerosis. Nat. Commun. 11, 3871 (2020).","journal-title":"Nat. Commun."},{"key":"40478_CR73","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1007\/s10585-022-10185-4","volume":"39","author":"SM Orbach","year":"2022","unstructured":"Orbach, S. M. et al. Single-cell RNA-sequencing identifies anti-cancer immune phenotypes in the early lung metastatic niche during breast cancer. Clin. Exp. Metastasis 39, 865\u2013881 (2022).","journal-title":"Clin. Exp. Metastasis"},{"key":"40478_CR74","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1016\/j.cell.2015.05.002","volume":"161","author":"E Macosko","year":"2015","unstructured":"Macosko, E. et al. Highly parallel genome-wide expression profiling of individual cells using nanoliter droplets. Cell 161, 1202\u20131214 (2015).","journal-title":"Cell"},{"key":"40478_CR75","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/nbt.4096","volume":"36","author":"A Butler","year":"2018","unstructured":"Butler, A., Hoffman, P., Smibert, P., Papalexi, E. & Satija, R. Integrating single-cell transcriptomic data across different conditions, technologies, and species. Nat. Biotechnol. 36, 411\u2013420 (2018).","journal-title":"Nat. Biotechnol."},{"key":"40478_CR76","doi-asserted-by":"publisher","first-page":"87","DOI":"10.4103\/ctm.ctm_69_16","volume":"3","author":"W Zhao","year":"2017","unstructured":"Zhao, W., Li, Y. & Zhang, X. Stemness-related markers in cancer. Cancer Transl. Med. 3, 87\u201395 (2017).","journal-title":"Cancer Transl. Med."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-40478-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-40478-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-40478-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T11:08:14Z","timestamp":1700219294000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-40478-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,8]]},"references-count":76,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["40478"],"URL":"https:\/\/doi.org\/10.1038\/s41467-023-40478-5","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,8]]},"assertion":[{"value":"25 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"L.D.S. and J.S.J. have a pending patent application with the scaffold technology (US-20200323893-A1, detection of metastatic disease and related methods). The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4790"}}